Medically reviewed content from Don R. Revis, Jr., MD, FACS, double board-certified plastic surgeon

Two terms come up often in breast implant research, and they’re frequently confused with one another: BIA-ALCL and breast implant illness (BII). They’re different things, backed by different levels of evidence, and worth understanding clearly and separately — not glossed over, and not sensationalized.

What Is BIA-ALCL?

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare cancer of the immune system — not breast cancer — that can develop in the scar tissue and fluid surrounding a breast implant. It is a recognized, regulator-acknowledged condition: the FDA has issued specific safety communications about it, and in some cases required manufacturers to withdraw certain implants from the market.

Which Implants Are Associated With BIA-ALCL Risk?

BIA-ALCL has been most strongly associated with certain textured-surface implants, particularly macro-textured styles, rather than smooth-shelled implants. This association is part of why implant texture is a relevant factor to discuss during any consultation, and why patients with textured implants placed years ago are sometimes advised to understand their specific implant history.

What Are the Symptoms of BIA-ALCL?

The most commonly reported symptom is a late-onset swelling around the implant, often caused by fluid buildup, typically occurring at least a year — and sometimes many years — after the original surgery. Persistent swelling, a lump, or pain around an implant that develops well after the initial healing period warrants prompt evaluation, since early diagnosis is associated with more favorable outcomes.

What Is Breast Implant Illness (BII)?

Breast implant illness is a term patients use to describe a range of symptoms — commonly including fatigue, joint pain, brain fog, and other systemic complaints — that they attribute to their breast implants. It’s a real experience reported by real patients, and it’s taken seriously in modern consultations, even though it works differently, medically, from BIA-ALCL.

Is BII a Recognized Medical Diagnosis?

Not currently, in the sense of being a single, distinctly defined diagnosis with an established test or biomarker. It is not classified as one specific condition by major regulatory or professional bodies. That said, the FDA has formally acknowledged patient-reported symptoms associated with breast implants and has taken steps in response — which is a different, more nuanced position than either dismissing the symptoms or confirming a specific causal mechanism.

What the FDA Requires Patients Be Told

Since 2021, the FDA has required that patients receive specific informed-consent materials before breast implant surgery, including a checklist that discloses reported symptoms associated with BII and information about BIA-ALCL risk. The intent is to make sure this isn’t a conversation patients have to seek out on their own — it’s built into informed consent as a standard part of the process.

What to Do If You’re Concerned About Your Implants

• Know your implant history: manufacturer, type (smooth vs. textured), and the date of your original surgery, if you don’t already have this on hand
• Report any new, persistent swelling, lump, or pain around an implant promptly, rather than waiting to see if it resolves
• If you’re experiencing systemic symptoms you associate with your implants, bring them directly to a consultation rather than researching in isolation — a surgeon can walk through your specific implant type and history with you
• Understand that explant (implant removal without replacement) is an option some patients pursue, separate from revision, if that’s the direction that makes sense for you

Frequently Asked Questions

Should I be worried if I have textured implants?

Textured implants are associated with a higher reported BIA-ALCL risk than smooth implants, but the condition remains rare overall. If you’re unsure what type you have, that’s a reasonable first question to bring to a consultation.

Is BIA-ALCL breast cancer?

No — it’s a type of lymphoma, a cancer of the immune system, that develops in tissue around the implant. It’s a distinct condition from breast cancer.

Can BII symptoms improve after implant removal?

Some patients report improvement in symptoms after explant, though this varies by individual and isn’t something current evidence can promise as a guaranteed outcome. It’s worth a direct conversation about your specific situation.

Do I need routine screening if I have breast implants?

The FDA has periodically recommended imaging screening for silicone implants specifically to check for silent rupture; ask your surgeon what’s appropriate for your implant type and how long you’ve had them.

If you have questions about your specific implant type, history, or symptoms you’re experiencing, schedule a consultation for a direct, evidence-based conversation.